Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Quezia Hall

Physician Assistant Show Low, AZ Physician Assistant

NPI 1073985651 CMS profile 10610942

4951 S White Mountain Rd Bldg A, Show Low, AZ 85901

Open in the dashboard

General payments

$1,610

30 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Quezia Hall of Show Low, AZ is reported in the CMS Open Payments database as having received $1,610 across 30 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $307 4
2024 General $273 6
2023 General $28 1
2022 General $33 2
2021 General $969 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Quezia Hall
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Quezia Hall were reported at $307. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Quezia Hall Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $969 $132 $37–$438 $132
2022 $33 $155 $48–$522 $149
2023 $28 $167 $52–$557 $160
2024 $273 $178 $55–$600 $164
2025 $307 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $945 16 payments
  2. Boston Scientific Corporation $349 6 payments
  3. Nevro Corp. $143 2 payments
  4. Abbott Laboratories $111 3 payments
  5. AbbVie, Inc. $28 1 payment
  6. Vertos Medical, Inc. $19 1 payment
  7. Foundation Fusion Solutions, LLC $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $1,231 26 payments
  2. Travel and Lodging $379 4 payments
Products named General payments · program years 2021–2025
  1. INTELLIS $857 13 payments
  2. Intracept Intracept Access Instruments (Gen 2)_NMOD $171 2 payments
  3. Senza $128 1 payment
  4. Intracept Intracept Access Instruments - Additional VB (Gen 3)_NMOD $74 1 payment
  5. ETERNA $68 1 payment
  6. Intracept Intracept Access Instruments (Gen 3)_NMOD $61 1 payment
  7. Vanta $55 1 payment
  8. BOTOX $28 1 payment
  9. Octrode SCS Leads $25 1 payment
  10. INTELLIS ADAPTIVESTIM $20 1 payment
  11. Other $82 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 27 drugs

Part D claims

2,966

Median for Physician Assistant: 241

Drug cost

$112,620

Median for Physician Assistant: $4,110

Branded share of claims

42.3%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Aimovig Autoinjector Erenumab-Aooe Brand 26 $19,870
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 579 $18,112
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 349 $16,281
Xtampza Er Oxycodone Myristate Brand 37 $11,639
Oxycodone Hcl Generic 451 $9,614
Gabapentin Generic 321 $5,324
Morphine Sulfate Er Morphine Sulfate Brand 207 $5,158
Oxycontin Oxycodone Hcl Brand 19 $4,118
Pregabalin Generic 104 $3,202
Fentanyl Generic 38 $2,590

The 10 drugs with the highest cost, of 27 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 8 billing codes

Paid by Medicare

$74,255

Medicare's payments for the services billed

Medicare patients

376

Average age 73

Services billed

1,554

223 women, 153 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Depression 30%
Diabetes 29%
COPD 26%
Ischemic heart disease 24%
Chronic kidney disease 24%
Osteoporosis 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

30 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record